Shanghai Junshi Biosciences UK Approval for Cancer Drug - TipRanks
688180 Stock | 28.19 0.29 1.04% |
About 52% of Shanghai Junshi's investor base is interested to short. The analysis of the overall investor sentiment regarding Shanghai Junshi Biosciences suggests that many traders are impartial. The current market sentiment, together with Shanghai Junshi's historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Junshi Bios stock news signals to limit their universe of possible portfolio assets.
Shanghai |
Shanghai Junshi Biosciences UK Approval for Cancer Drug TipRanks
Read at news.google.com
Shanghai Junshi Fundamental Analysis
We analyze Shanghai Junshi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Junshi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Junshi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Shanghai Junshi is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Shanghai Junshi Bios Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shanghai Junshi stock to make a market-neutral strategy. Peer analysis of Shanghai Junshi could also be used in its relative valuation, which is a method of valuing Shanghai Junshi by comparing valuation metrics with similar companies.
Peers
Shanghai Junshi Related Equities
603077 | Sichuan Hebang | 1.44 | ||||
002702 | HaiXin Foods | 1.33 | ||||
300498 | Guangdong Wens | 1.25 | ||||
603697 | Youyou Foods | 0.99 | ||||
001219 | Qingdao Foods | 0.78 | ||||
688193 | Shanghai Rendu | 0.67 | ||||
603057 | Shanghai Ziyan | 1.94 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |